Literature DB >> 16775221

Evaluation of patients with paramyotonia at 23Na MR imaging during cold-induced weakness.

Marc-André Weber1, Sonia Nielles-Vallespin, Hagen B Huttner, Johannes C Wöhrle, Karin Jurkat-Rott, Frank Lehmann-Horn, Lothar R Schad, Hans-Ulrich Kauczor, Marco Essig, Hans-Michael Meinck.   

Abstract

PURPOSE: To prospectively examine whether sodium 23 (23Na) magnetic resonance (MR) imaging can be used to visualize acute intracellular Na+ accumulation and the effects of specific therapy in patients with paramyotonia congenita (PC).
MATERIALS AND METHODS: Ethics committee approval and informed consent were obtained. Sixteen patients (four women, 12 men; mean age, 46.7 years +/- 16.7 [standard deviation]) with confirmed PC and 10 healthy volunteers (three women, seven men; mean age, 26.6 years +/- 3) were examined by using a 1.5-T MR system with a 16.8-MHz surface coil. 23Na MR imaging was performed before and after local cooling of the nondominant lower leg and exercising, with experimentally induced weakness scored by a neurologist. The 23Na MR examination was repeated in 13 patients and all volunteers after 3 days and, additionally, in seven patients after 4 days of oral administration of mexiletine, which blocks Na+ channels. The 23Na MR protocol comprised two-dimensional (2D) fast low-angle shot (FLASH), 2D radial, and free induction decay (FID) sequences. The FID data were fitted to a biexponential decay curve to evaluate the slow and fast components of the T2 relaxation time. Fast and slow components were assigned to intra- and extracellular Na+ concentrations, respectively. Radial and FLASH MR images were evaluated by means of a region-of-interest analysis by using 0.3% saline solution for reference. T1- and T2-weighted MR imaging were also performed. Data were analyzed by using a parametric t test.
RESULTS: After exercising, all patients developed considerable weakness exclusively in the cooled lower leg; no weakness was observed in volunteers. In patients, all 23Na MR images showed a significant increase in 23Na signal intensity in the cooled lower leg (P < .001) in comparison with nonsignificant findings in volunteers. After treatment with mexiletine, cooling and exercise induced almost no muscle weakness and no changes in 23Na MR signal intensity in patients.
CONCLUSION: 23Na MR imaging enables visualization of muscular Na+ accumulation associated with muscle weakness in patients with PC, and effects of specific therapy can be detected. RSNA, 2006

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775221     DOI: 10.1148/radiol.2401050737

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

Review 1.  MR Imaging of the Musculoskeletal System Using Ultrahigh Field (7T) MR Imaging.

Authors:  Hamza Alizai; Gregory Chang; Ravinder R Regatte
Journal:  PET Clin       Date:  2018-10

Review 2.  Sodium MRI in human heart: a review.

Authors:  Paul A Bottomley
Journal:  NMR Biomed       Date:  2015-02-12       Impact factor: 4.044

Review 3.  Biochemical and physiological MR imaging of skeletal muscle at 7 tesla and above.

Authors:  Gregory Chang; Ligong Wang; Arturo Cárdenas-Blanco; Mark E Schweitzer; Michael P Recht; Ravinder R Regatte
Journal:  Semin Musculoskelet Radiol       Date:  2010-05-18       Impact factor: 1.777

4.  Double trouble in a patient with myotonia.

Authors:  Michael K Hehir; Eric Logigian; Dipa L Raja Rayan; Emma Ciafaloni
Journal:  BMJ Case Rep       Date:  2013-02-14

5.  3D 23Na MRI of human skeletal muscle at 7 Tesla: initial experience.

Authors:  Gregory Chang; Ligong Wang; Mark E Schweitzer; Ravinder R Regatte
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

Review 6.  Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias.

Authors:  Daniel Platt; Robert Griggs
Journal:  Curr Opin Neurol       Date:  2009-10       Impact factor: 5.710

Review 7.  The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Authors:  E Matthews; D Fialho; S V Tan; S L Venance; S C Cannon; D Sternberg; B Fontaine; A A Amato; R J Barohn; R C Griggs; M G Hanna
Journal:  Brain       Date:  2009-11-16       Impact factor: 13.501

Review 8.  Neuromuscular imaging in inherited muscle diseases.

Authors:  Mike P Wattjes; Rudolf A Kley; Dirk Fischer
Journal:  Eur Radiol       Date:  2010-04-27       Impact factor: 5.315

9.  Functional imaging in muscular diseases.

Authors:  Erick Amarteifio; Armin Michael Nagel; Hans-Ulrich Kauczor; Marc-André Weber
Journal:  Insights Imaging       Date:  2011-06-28

Review 10.  Sodium channelopathies of skeletal muscle and brain.

Authors:  Massimo Mantegazza; Sandrine Cestèle; William A Catterall
Journal:  Physiol Rev       Date:  2021-03-26       Impact factor: 46.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.